|
|
 |
Trastuzumab-resistant MBC Responds to Lapatinib
ISSUE: AUGUST, 2008
Lapatinib significantly improves progression-free survival (PFS) in heavily pretreated patients with human epidermal growth receptor factor 2 (HER2)- positive metastatic breast cancer who have progressed on their last trastuzumab-containing regimen, according to a recent study.
read more |
When Used as Maintenance Therapy, Pemetrexed Improves PFS in Patients With Advanced NSCLC
ISSUE: AUGUST, 2008
A multicenter Phase III trial has revealed that maintenance therapy with pemetrexed improved progression-free survival (PFS) in patients with advanced non-small cell lung cancer (NSCLC), according to a study presented at the annual meeting of the American Society of Clinical Oncology (abstract 8011).
read more |
Earlier Use of Palliative Care Services Might Increase Their Benefit
ISSUE: AUGUST, 2008
Oncologists should increase efforts to refer patients to palliative care at an earlier stage. Although awareness of palliative care may have improved, doctors are not referring patients to palliative care earlier, according to investigators at the University of Texas M.D. Anderson Cancer Center in Houston.
read more |
Protect Your Practice With an Annual Expense Check-Up
ISSUE: AUGUST, 2008
Increasing operating costs, declining reimbursement and tighter margins mandate that you take a closer look at your practice on a regular basis and assess your financial situation. Today, even large practices are struggling to manage expenses. Changes created by ASP+ payment and regulations on ESA usage have significantly reduced revenue for oncology practices. For diversified practices, changes in payment for diagnostic radiology and ambulatory surgery have also placed stress on practice resources. We anticipate that payment reductions for radiation will follow.
read more |
|
 |
|